Source: Eur Respir J 2012; 39: 1033-1034
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Travers J., Weatherall M., Fingleton J., Beasley R.. Towards individualised medicine for airways disease: identifying clinical phenotype groups. Eur Respir J 2012; 39: 1033-1034

Member's Comments

No comment yet.

Related content which might interest you: Distinct clinical phenotypes of airways disease: a primary-care clinician perspective Source: Eur Respir J 2010; 35: 459 Year: 2010 Assessing the effect of medical therapy in COPD: from pathophysiology and biomarkers to clinical practice Source: Annual Congress 2009 - PG15 The complexity of COPD: assessment and advanced therapies Year: 2009 A critical evaluation of the relevance of different asthma phenotypes for clinical practice Source: Annual Congress 2008 - A step-change in asthma. The Lancet/ERS symposium Year: 2008 The future of disease monitoring and management: the homework for clinical researchers Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not? Year: 2005 Treatment of COPD by clinical phenotypes: putting old evidence into clinical practice Source: Eur Respir J 2013; 41: 1252-1256 Year: 2013 “To define is to limit”: perspectives on asthma–COPD overlap syndrome and personalised medicine Source: Eur Respir J, 49 (5) 1700336; 10.1183/13993003.00336-2017 Year: 2017 Does a predominant clinical COPD phenotype predict different outcome responses to pulmonary rehabilitation? Source: Annual Congress 2012 - The best posters in pulmonary rehabilitation and chronic care Year: 2012 The disease model: implications for clinical practice Source: Eur Respir J, 51 (4) 1800188; 10.1183/13993003.00188-2018 Year: 2018 An international survey on genetics in clinical practice for interstitial lung disease. Source: Virtual Congress 2021 – Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseases Year: 2021 Integrating patients with respiratory and cardiac disease in one rehabilitation programme: clinical outcomes of a pragmatic service evaluation. Source: International Congress 2019 – Innovations in care for chronic respiratory conditions Year: 2019 Rethinking the way we are treating established airway disease: current guidelines need to change  Source: International Congress 2016 – Presentation and discussion of a draft Lancet Commission on Asthma Year: 2016 NOVELTY: a landmark study in phenotyping and endotyping chronic obstructive airway diseases in real clinical practice Source: Eur Respir J, 58 (3) 2100627; 10.1183/13993003.00627-2021 Year: 2021 Distribution of COPD phenotypes according to the Spanish COPD guidelines in clinical practice Source: International Congress 2015 – Notable abstracts in COPD: variety Year: 2015 COPD: different psychology changes in the patients with different severity of disease Source: Annual Congress 2007 - Clinical aspects of COPD II Year: 2007 The future of treatment for interstitial lung diseases: the patient’s and physician’s perspective Source: International Congress 2019 – Rare lung diseases Year: 2019 Linking phenotypes to personalised treatments in asthma and COPD Source: Virtual Congress 2021 – Precision medicine in asthma and COPD Year: 2021 Measuring inflammation inpaediatric severe asthma: biomarkers in clinical practice Source: Breathe, 16 (1) 190301; 10.1183/20734735.0301-2019 Year: 2020 Evaluation of the use of e-learning in training management of asthma and COPD in general medicine. Source: International Congress 2017 – Medical education, web and internet Year: 2017 The clinical impact of adherence to therapy in airways disease Source: Breathe, 17 (2) 210039; 10.1183/20734735.0039-2021 Year: 2021